IMDEX LIMITED (IMD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IMD

IMD - IMDEX LIMITED

FNArena Sector : Mining Sector Contracting
Year End: June
GICS Industry Group : Materials
Debt/EBITDA: 0.81
Index: ASX200 | ASX300 | ALL-ORDS

Imdex is an Australian mining tech company. It manufacturers & provides drilling fluids, chemicals, mining instumentation and data & geo-analytical services. Formed in 1980, it became a listed company in 1987.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.53

27 Oct
2025

-0.020

OPEN

$3.57

-0.56%

HIGH

$3.60

979,046

LOW

$3.53

TARGET
$3.74 5.9% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . ARI . C79 . CDA . DNL . DOW . EHL . GNG . IPG . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . ORI . PRN . RAN . RCR . RUL . SGH . SRG . SXE . XRF .
FNARENA'S MARKET CONSENSUS FORECASTS
IMD: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 10.8 11.0 xxx
DPS (cps) xxx 2.5 4.0 xxx
EPS Growth xxx 69.5% 2.0% xxx
DPS Growth xxx - 9.6% 58.1% xxx
PE Ratio xxx N/A 31.5 xxx
Dividend Yield xxx N/A 1.2% xxx
Div Pay Ratio(%) xxx 23.5% 36.4% xxx

Dividend yield today if purchased 3 years ago: 1.23%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.73

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 25/09 - ex-div 1.30c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx10.8
DPS All xxxxxxxxxxxxxxx2.5
Sales/Revenue xxxxxxxxxxxxxxx431.4 M
Book Value Per Share xxxxxxxxxxxxxxx123.0
Net Operating Cash Flow xxxxxxxxxxxxxxx123.5 M
Net Profit Margin xxxxxxxxxxxxxxx12.79 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx9.19 %
Return on Invested Capital xxxxxxxxxxxxxxx7.96 %
Return on Assets xxxxxxxxxxxxxxx6.83 %
Return on Equity xxxxxxxxxxxxxxx9.19 %
Return on Total Capital xxxxxxxxxxxxxxx9.95 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx62.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx8 M
Long Term Debt xxxxxxxxxxxxxxx93 M
Total Debt xxxxxxxxxxxxxxx100 M
Goodwill - Gross xxxxxxxxxxxxxxx325 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx43 M
Price To Book Value xxxxxxxxxxxxxxx2.21

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx57.4 M
Capex % of Sales xxxxxxxxxxxxxxx13.30 %
Cost of Goods Sold xxxxxxxxxxxxxxx303 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx58 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx8 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

09/10/2025

2

Upgrade to Accumulate from Hold

$3.80

7.65%

Morgans upgrades Imdex to Accumulate from Hold with a higher target of $3.80 from $3.45 ahead of the company's 1Q26 sales update at the AGM next week, which the analyst believes will come in above expectations.

Junior raisings have increased to record levels in September of US$1.5bn, up 260% on the prior year, with Morgans pointing to a pick-up in other commodities, including sustained gains in the gold price..

Non-precious metals raisings grew 345% on last year versus precious metals up 44% over the same period, marking the fourth consecutive month of raisings over US$1bn. Trailing 12-month raisings are up 72% to US$11.1bn on the prior period.

The analyst raises Imdex's revenue growth forecast to 16% for FY26 from 14%, and to 7% from 5% in FY27, with an associated rise in NPATA estimates by 3% in FY26 and 7%-9% in FY27-28, respectively.

FORECAST
Morgans forecasts a full year FY26 dividend of 4.30 cents and EPS of 12.00 cents.
Morgans forecasts a full year FY27 dividend of 4.70 cents and EPS of 14.00 cents.

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

22/10/2025

5

Sell

$2.75

-22.10%

Imdex’s first quarter update revealed revenue growth of 10% year-on-year, marking an acceleration from the prior quarter, highlights Jarden.

Q1 revenue rose 10% year-on-year to $123m, the highest level expected by the broker for the first half due to seasonal factors. It's noted trading conditions were mixed, with solid demand in key markets and sustained strength across EMEA providing the main positive.

The stock price remains heavily extended following the FY25 result, in the broker's view, trading more than two standard deviations above its long-term average relative to the ASX200 ex-Resources.

Jarden maintains a Sell rating and a $2.75 target price.
Access Extra Coverage Research History >

IMD STOCK CHART

FNArena News on IMD

1
Rudi’s View: ALS, Bega, Coles, Elders, Light & Wonder, Lovisa, Telix & More

Oct 23 2025 - Rudi's View
2
Australian Broker Call *Extra* Edition – Oct 22, 2025

Oct 22 2025 - Daily Market Reports
3
Weekly Ratings, Targets, Forecast Changes – 17-10-25

Oct 20 2025 - Weekly Reports
4
Weekly Ratings, Targets, Forecast Changes – 10-10-25

Oct 13 2025 - Weekly Reports
5
Rudi’s View: AI Boom Reveals Our Inner Bias

Oct 01 2025 - Rudi's View

Latest Mining Sector Contracting News

1
Another Step-Change In Growth For SRG Global

Oct 22 2025 - Small Caps
2
A Fresh Upgrade Cycle For Monadelphous?

Sep 11 2025 - Australia
3
NRW Holdings Happily Says Goodbye To FY25

Aug 27 2025 - Small Caps
4
Treasure Chest: Imdex

Jul 31 2025 - Treasure Chest
5
Dyno Nobel Flicks The Switch To Blasting

May 15 2025 - Australia
6
When The Cyclical Leg Up For Imdex?

May 08 2025 - Commodities
7
Orica’s Transformation Proceeding Apace

Mar 24 2025 - Australia
8
NRW Holdings: Navigating The OneSteel Risk

Mar 05 2025 - Small Caps
9
Chrysos Corp’s Road Paved With Gold

Jan 24 2025 - Small Caps
10
Orica Shares Eyeing $21

Dec 10 2024 - Technicals